Format

Send to

Choose Destination
See comment in PubMed Commons below
AIDS Read. 2008 May;18(5):242-6, 252-6, 262-4.

Impact of lipoatrophy on patient-reported outcomes in antiretroviral-experienced patients.

Author information

  • 1Galen Research Ltd, Manchester, United Kingdom.

Abstract

Lipoatrophy is a noteworthy adverse effect of antiretroviral therapy. A 2-part literature review was conducted to assess the impact of lipoatrophy in HIV-infected persons: the first reviewed the qualitative studies that reported lipoatrophy data, and the second reviewed the clinical studies that recorded patient-reported outcome end points. This literature review provided considerable evidence that lipoatrophy has a negative impact on the psychosocial well-being and health-related quality of life of HIV-infected persons receiving antiretroviral therapy. However, the patient-reported outcome measures used in clinical studies were not lipoatrophy-specific and had limited ability to show real changes in health status associated with lipoatrophy.

PMID:
18589480
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk